Zusammenfassung
Luftnot gehört zu den häufigsten und besonders belastenden Symptomen bei Patienten mit einer inkurablen Tumorerkrankung. Grundsätzlich sind direkt tumorbedingte, tumor- und therapieassoziierte sowie tumorunabhängige Ursachen zu unterscheiden. Die spezifische Behandlung umfasst zunächst den Ausschluss iatrogener Ursachen, Punktion bei Ergüssen, Heparinbehandlung bei Pulmonalarterienembolien, Einlage von Stents, Steroidtherapie und ggf. bronchodilatorische Therapie. Zur symptomatischen Behandlung werden Opioide, Sauerstoff, Anxiolytika und inhalative Maßnahmen eingesetzt.
Abstract
Shortness of breath is one of the commonst and most distressing symptoms experienced by patients with incurable tumour disease. It is essential to find out whether it is caused directly by the tumour or associated with the tumour and its treatment, or whether its aetiology has nothing to do with the tumour. Specific treatment implies initial exclusion of iatrogenic aetiologies, pleural puncture when pleural effusion is present, heparin treatment in the case of pulmonary artery embolisms, insertion of stents, steroid therapy and, if appropriate, treatment with bronchodilators. Opioids, oxygen, anxiolytics and inhalations are used for symptomatic treatment.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Achmedzai S (1998) Palliation of Respiratory Symptoms. In: Doyle D, Hanks GWC, Mac Donald N (eds) Oxford Textbook of Palliative Medicine, pp 583–602
Allard P, Lamontagne C, Bernard P, Tremblay C (1999) How Effective Are Supplementary Doses of Opioids for Dyspnea in Terminally Ill Cancer Patients? A Randomized Continuous Sequential Clinical Trial. J Pain Sympt Manag 17:256–265
Booth S, Kelly MJ, Cox NP, Adams L, Guz A (1996) Does Oxygen Help Dyspnea in Patients with Cancer? Am J Respir Crit Care Med 153:1515–1518
Booth S, Wade R (2003) Oxygen or air for palliation of breathlessness in advanced cancer. J R Soc Med 96:215–218
Bredin M, Krishnasamy M, Corner J, Plant H, Bailey C, A’Hern R (1999) Multicenter Randomised Controlled Trial of Nursing Intervention for Breathlessness in Patients with Lung Cancer. BMJ 318:901–904
Bruera E, MacEachern T, Ripamonti C, Hanson J (1993) Subcutaneus Morphine for Dyspnea in Cancer Patients. Ann Intern Med 119:906–907
Bruera E, de Stoutz N, Velasco-Leiva X, Schoeller T, Hanson J (1993) Effects of Oxygen in Hypoxaemic Terminal-Cancer Patients. Lancet 342:13–14
Corner J, Plant H, A’Hern R, Bailey C (1996) Non-Pharmacological Intervention for Breathlessness in Lung Cancer. Pall Med 10:299–305
Dudgeon DJ, Lertzman M, Askew GR (2001) Physiological Changes and Clinical Correlations of Dyspnea in Cancer Outpatients. J Pain Sympt Manag 21:373–379
Manning HL, Schwartzstein RM (1995) Pathophysiology of Dyspnea. NEJM 23:1547–1553
Monti M, Castellani L, Berlusconi A, Cunietti E (1996) Use of Red Blood Cell Transfusions in Terminally Ill Cancer Patients Admitted to a Palliative Care Unit. J Pain Sympt Manag 12:18–22
Moragón-Martinez E, Aparicio J, Sanchis J, Menédez R, Rogado MC, Sanchis F (1998) Malignant Pleural Effusion: Prognostic Factors for Survival and Response to Chemical Pleurodesis in a Series of 120 Cases. Respir 65:108–113
Ripamonti C (1999) Management of Dyspnea in Advanced Cancer Patients. Support Care Cancer:233–243
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strohscheer, I., Samonigg, H. Behandlung von Luftnot bei fortgeschrittenen Tumorerkrankungen. Onkologe 11, 407–412 (2005). https://doi.org/10.1007/s00761-005-0851-3
Issue Date:
DOI: https://doi.org/10.1007/s00761-005-0851-3